• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hormone replacement therapy.

作者信息

Barrett-Connor E

机构信息

Department of Family and Preventive Medicine, University of California at San Diego, La Jolla, CA 92093-0607, USA.

出版信息

BMJ. 1998 Aug 15;317(7156):457-61. doi: 10.1136/bmj.317.7156.457.

DOI:10.1136/bmj.317.7156.457
PMID:9703530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1113713/
Abstract
摘要

相似文献

1
Hormone replacement therapy.激素替代疗法
BMJ. 1998 Aug 15;317(7156):457-61. doi: 10.1136/bmj.317.7156.457.
2
A hard look at hormone replacement.对激素替代疗法的深入审视。
Bus Health. 1997 May;15(5):48, 50-1.
3
Decision factors influencing hormone replacement therapy.影响激素替代疗法的决策因素。
Br J Obstet Gynaecol. 1996 May;103 Suppl 13:92-7; discussion 97-8.
4
[Endocrine system. a. Hormone replacement therapy--improvement of in bone metabolism and cancer risk of long term therapy].[内分泌系统。a. 激素替代疗法——长期治疗对骨代谢的改善及癌症风险]
Nihon Sanka Fujinka Gakkai Zasshi. 1994 Aug;46(8):749-63.
5
Hormone replacement therapy, breast and endometrial cancer.激素替代疗法、乳腺癌和子宫内膜癌。
Eur J Cancer Prev. 1996 Oct;5(5):414-6.
6
The menopause: benefits and risks of hormone replacement therapy.
Compr Ther. 1994;20(10):580-5.
7
[Risks, benefits and costs of hormone replacement therapy in menopause].[更年期激素替代疗法的风险、益处及成本]
Rev Med Liege. 1998 May;53(5):298-304.
8
Hormone replacement therapy (HRT)--risks and benefits.
Int J Epidemiol. 2001 Jun;30(3):423-6. doi: 10.1093/ije/30.3.423.
9
Hormone replacement therapy and malignancy.激素替代疗法与恶性肿瘤
Br J Obstet Gynaecol. 1993 May;100(5):408-10. doi: 10.1111/j.1471-0528.1993.tb15262.x.
10
Page for patients. A message from Preventive Medicine and your physician.
Prev Med. 1999 May;28(5):465-6.

引用本文的文献

1
What Do Women in Rural Tamil Nadu Think about Postmenopausal Bleeding? A Mixed-Method Study.泰米尔纳德邦农村地区的女性对绝经后出血有何看法？一项混合方法研究。
Indian J Community Med. 2021 Jan-Mar;46(1):145-148. doi: 10.4103/ijcm.IJCM_446_20. Epub 2021 Mar 1.
2
Knowledge of reproductive physiology and hormone therapy in 40-60 year old women: a population-based study in Yazd, Iran.40至60岁女性生殖生理学与激素治疗知识：伊朗亚兹德的一项基于人群的研究
Iran J Reprod Med. 2012 Jul;10(4):383-90.
3
Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?雌激素 - 孕激素绝经激素治疗与乳腺癌：从绝经开始到治疗开始的延迟会影响风险吗？
J Clin Oncol. 2009 Nov 1;27(31):5138-43. doi: 10.1200/JCO.2008.21.6432. Epub 2009 Sep 14.
4
New thoughts about estrogen therapy from the Women's Health Initiative.来自女性健康倡议组织关于雌激素疗法的新观点。
Curr Osteoporos Rep. 2008 Sep;6(3):108-13. doi: 10.1007/s11914-008-0019-3.
5
Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003.1998年至2003年间德国女性更年期激素疗法使用情况的差异。
BMC Womens Health. 2007 Oct 18;7:19. doi: 10.1186/1472-6874-7-19.
6
Socioeconomic position and hormone replacement therapy use: explaining the discrepancy in evidence from observational and randomized controlled trials.社会经济地位与激素替代疗法的使用：解释观察性研究与随机对照试验证据中的差异。
Am J Public Health. 2004 Dec;94(12):2149-54. doi: 10.2105/ajph.94.12.2149.
7
[Should the menopause be treated?].[更年期应该治疗吗？]
Aten Primaria. 2004 Mar 15;33(4):203-8. doi: 10.1016/s0212-6567(04)79395-6.
8
A case-control study on the effect of hormone replacement therapy on ischaemic heart disease.一项关于激素替代疗法对缺血性心脏病影响的病例对照研究。
Br J Gen Pract. 2003 Mar;53(488):191-6.
9
Optimisation of treatment by applying programmable rate-controlled drug delivery technology.应用可编程速率控制药物递送技术优化治疗。
Clin Pharmacokinet. 2002;41(15):1267-99. doi: 10.2165/00003088-200241150-00003.
10
Identifying patient preferences for communicating risk estimates: a descriptive pilot study.识别患者对传达风险评估结果的偏好：一项描述性试点研究。
BMC Med Inform Decis Mak. 2001;1:2. doi: 10.1186/1472-6947-1-2. Epub 2001 Aug 1.

本文引用的文献

1
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.乳腺癌与激素替代疗法：对51项流行病学研究数据的联合重新分析，涉及52705例乳腺癌女性和108411例非乳腺癌女性。乳腺癌激素因素协作组
Lancet. 1997 Oct 11;350(9084):1047-59.
2
Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.心脏与雌激素/孕激素替代治疗研究（HERS）：设计、方法及基线特征
Control Clin Trials. 1998 Aug;19(4):314-35. doi: 10.1016/s0197-2456(98)00010-5.
3
Hormone replacement therapy, heart disease, and other considerations.激素替代疗法、心脏病及其他注意事项。
Annu Rev Public Health. 1998;19:55-72. doi: 10.1146/annurev.publhealth.19.1.55.
4
Myth and paradox of coronary risk and the menopause.冠心病风险与更年期的误区及矛盾
Lancet. 1998 May 9;351(9113):1425-7. doi: 10.1016/S0140-6736(97)11321-6.
5
Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group.
Arch Intern Med. 1997;157(22):2609-15. doi: 10.1001/archinte.157.22.2609.
6
Estrogen therapy in postmenopausal women: effects on cognitive function and dementia.绝经后女性的雌激素治疗：对认知功能和痴呆症的影响。
JAMA. 1998 Mar 4;279(9):688-95. doi: 10.1001/jama.279.9.688.
7
Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis.钙增强雌激素和降钙素对骨量的作用：综述与分析。
Am J Clin Nutr. 1998 Jan;67(1):18-24. doi: 10.1093/ajcn/67.1.18.
8
Randomized trial of osteoporosis screening. Use of hormone replacement therapy and quality-of-life results.骨质疏松症筛查的随机试验。激素替代疗法的使用及生活质量结果。
Arch Intern Med. 1997 Oct 13;157(18):2121-5. doi: 10.1001/archinte.157.18.2121.
9
Hormone replacement therapy and risk of non-fatal stroke.激素替代疗法与非致死性中风风险
Lancet. 1997 Nov 1;350(9087):1277-83. doi: 10.1016/S0140-6736(97)06005-4.
10
Estrogen replacement therapy and mortality among older women. The study of osteoporotic fractures.雌激素替代疗法与老年女性死亡率。骨质疏松性骨折研究。
Arch Intern Med. 1997 Oct 27;157(19):2181-7.